Context Therapeutics Income Statement (2020-2026) | CNTX

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
1.33M0.74M1.29M1.35M1.52M2.08M2.14M4.53M3.46M4.49M5.30M1.97M1.38M16.83M2.52M3.46M7.83M8.72M11.84M7.02M
Selling, General & Administrative (Quarter)
0.60M0.83M1.80M2.09M1.99M1.97M1.74M2.13M1.83M1.70M1.63M1.85M1.70M1.88M1.79M2.07M1.93M1.89M1.96M2.33M
Other Operating Expenses (Quarter)
-1.93M-3.09M-17.27M-3.39M-4.47M-8.31M-9.37M-12.43M-7.44M
Operating Expenses (Quarter)
1.94M1.57M3.09M3.44M3.51M4.05M3.88M6.67M5.29M6.18M6.93M1.89M1.43M0.92M1.06M1.45M1.24M1.37M1.90M
Operating Income (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.82M-3.09M-18.70M-4.31M-5.53M-9.76M-10.61M-13.80M-9.34M
EBIT (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.82M-3.09M-18.70M-4.31M-5.53M-9.76M-10.61M-13.80M-9.34M
Non-operating items
Interest & Investment Income (Quarter)
0.15M0.84M1.24M0.96M0.96M0.90M0.83M0.68M0.52M
Other Non Operating Income (Quarter)
0.00M-0.01M-0.00M0.00M-0.01M0.03M0.08M0.10M0.14M
Non Operating Income (Quarter)
-0.00M0.13M-276.00-0.00M4.000.00M-0.00M0.00M-0.01M0.02M-0.06M0.00M-0.01M-0.00M0.00M-0.01M0.03M0.08M0.10M0.14M
Net income details
EBT (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.67M-2.25M-17.46M-3.35M-4.57M-8.85M-9.78M-13.12M-8.82M
Profit After Tax (Quarter)
-5.03M-1.44M-3.09M-3.44M-3.99M-3.85M-3.56M-6.31M-5.01M-5.87M-6.77M-3.67M-2.25M-17.46M-3.34M-4.58M-8.83M-9.69M-13.03M-8.68M
Income from Continuing Operations (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.67M-2.25M-17.46M-3.35M-4.57M-8.85M-9.78M-13.12M-8.82M
Consolidated Net Income (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.67M-2.25M-17.46M-3.35M-4.57M-8.85M-9.78M-13.12M-8.82M
Income towards Parent Company (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.67M-2.25M-17.46M-3.35M-4.57M-8.85M-9.78M-13.12M-8.82M
Net Income towards Common Stockholders (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.67M-2.25M-17.46M-3.35M-4.57M-8.85M-9.78M-13.12M-8.82M
Additional items
EPS (Basic) (Quarter)
-14.18-4.0017.05-0.22-0.25-0.24-0.22-0.40-0.31-0.37-0.42-0.23-0.04-0.22-0.06-0.05-0.09-0.10-0.14-0.09
EPS (Weighted Average and Diluted) (Quarter)
-14.18-4.0017.05-0.22-0.25-0.24-0.22-0.40-0.31-0.37-0.42-0.23-0.04-0.22-0.06-0.05-0.09-0.10-0.14-0.09
Shares Outstanding (Weighted Average) (Quarter)
0.35M0.48M2.83M15.97M15.97M15.97M15.97M5.86M5.86M15.97M15.97M5.86M35.46M50.58M58.42M11.34M11.34M95.19M95.19M95.18M
Shares Outstanding (Diluted Average) (Quarter)
0.35M0.36M2.83M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M35.46M80.48M58.42M95.19M95.19M95.19M95.19M95.18M
EBITDA (Quarter)
-5.03M-1.57M-3.09M-3.44M-4.01M-4.05M-3.88M-6.67M-5.29M-6.18M-6.93M-3.82M-3.09M-18.70M-4.31M-5.53M-9.76M-10.61M-13.80M-9.34M
Interest Expenses (Quarter)
0.00M-315.00
Shares Outstanding (Quarter)
0.34M0.35M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M15.97M75.00M75.00M89.70M89.70M89.70M91.88M91.88M91.88M